Profit Or Loss [Abstract]

Hyloris Pharmaceuticals SA - Filing #3166254

Concept 2022-01-01 to
2022-12-31
2021-01-01 to
2021-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue
2,951 EUR
3,096 EUR
Cost of sales
94,000 EUR
107,000 EUR
Gross profit
2,857 EUR
2,988 EUR
Profit (loss) from operating activities
10,638 EUR
10,541 EUR
Finance income
466,000 EUR
32,000 EUR
Finance costs
594,000 EUR
773,000 EUR
Share of profit (loss) of associates and joint ventures accounted for using equity method
130,000 EUR
191,000 EUR
Profit (loss) before tax
10,766 EUR
11,282 EUR
Tax expense (income)
4,000 EUR
297,000 EUR
Profit (loss)
10,770 EUR
11,579 EUR
Profit (loss), attributable to [abstract]
Profit (loss), attributable to owners of parent
10,770 EUR
11,579 EUR
Earnings per share [text block]
Earnings per share [abstract]
Earnings per share [line items]
Basic earnings per share [abstract]
Basic earnings (loss) per share from continuing operations
40.00
45.00

Talk to a Data Expert

Have a question? We'll get back to you promptly.